Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

5204602349_c87b204860_z

FDA approves RNA therapy for rare genetic disease

August 13, 2018 Sales and Marketing FDA, Onpattro, Orphan Drugs, RNA, rare diseases

The US Food and Drug Administration has approved the RNA-based therapy Onpattro, for the treatment of the rare genetic disease …
News
abbvie_0

Chicago Judge overturns $140 million AbbVie AndroGel verdict

August 13, 2018 Sales and Marketing AbbVie, Litigation, androgel, legal, testosterone

A US Judge has overturned a $140.1 million verdict against the New York-listed AbbVie Inc. The verdict, which ruled in …
News
fdaoutsideweb

FDA approves first oral therapy for rare Fabry disease

August 13, 2018 Sales and Marketing FDA, Fabry disease, US, pharma

Amicus has revealed that its therapy Galafold (migalastat) has been awarded approval by the FDA in the treatment of adult …
News
nhs_sign

NHS scraps restriction on availability of J&J’s Imbruvica in leukaemia patients

August 10, 2018 Medical Communications, Sales and Marketing Cancer, J&J, JJ, Johnson & Johnson, NHS, NICE, UK, imbruvica, leukaemia, pharma

The NHS has dropped a controversial restriction preventing leukaemia patients from accessing Johnson & Johnson’s tyrosine kinase inhibitor Imbruvica (ibrutinib), …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ADHD, Allergan, MHRA, UK, brexit, iraq, pharma, top 10

There was some clarity on Brexit this week as the MHRA set out a plan for the implantation period set …
News
rep

US Congressman arrested over insider trading in biopharma firm

August 9, 2018 Research and Development, Sales and Marketing Chris Collins, Innate, Innate Immunotherapeutics, US, congress, multiple sclerosis, pharma

A Republican Congressman has been arrested by the FBI over on charges of insider trading with shares in Australian biopharmaceutical …
News

NICE recommends Eli Lilly’s psoriatic arthritis drug

August 9, 2018 Research and Development, Sales and Marketing Eli Lilly, England, NICE, Wales, psoriatic arthritis

Eli Lilly have announced that the monoclonal antibody ixekizumab, has been recommended by NICE for use as a treatment option …
News

NICE recommends Pfizer’s Besponsa in rare leukaemia following review

August 9, 2018 Sales and Marketing NICE, Pfizer, leukaemia, pharma

Pfizer has revealed that NICE has finally decided to recommend its CD22-targeting monoclonal antibody Besponsa (inotuzumab ozogamicin) in the treatment …
News

Insys Therapeutics reaches $150m agreement to settle opioid marketing case

August 9, 2018 Medical Communications, Sales and Marketing Litigation, Subsys, US Department of Justice, fentanyl, insys, opioid, pharma

The Arizona-based pharma company Insys Therapeutics has reached an agreement to pay $150 million to the US Department of Justice …
News
AstraZeneca

AstraZeneca to pay $110m to settle allegations of fraudulent marketing in Texas

August 8, 2018 Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Texaas, US, pharma

AstraZeneca has backed down in a dispute with the State of Texas over allegations it had defrauded the state’s Medicaid …
News

GSK appoint HSBC director Iain Mackay as new CFO

August 7, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Iain Mckay, cfo, hsbc

British pharma giant GlaxoSmithKline have appointed HSBC Group Finance Director, Iain Mackay, as its new Chief Financial Officer. The move …
Appointment
shutterstock_79370437

Ironwood returns US Zurampic rights to AstraZeneca, announces operational cuts

August 7, 2018 Manufacturing and Production, Sales and Marketing AstraZeneca, Ironwood, Zurampic, gout, pharma

Ironwood Pharmaceuticals has revealed that it has taken the decision to hand the rights for gout therapy Zurampic (lesinurad) back …
News

Pain Therapeutics refocuses on Alzheimer’s after FDA turns down abuse-deterrent opioid painkiller

August 7, 2018 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Remoxy, opioid crisis, opioids, pain therapeutics, pharma

The FDA has voted to reject Texas-based Pain Therapeutics’ abuse deterrent opioid painkiller Remoxy (oxycodone), leading the company to consider …
News
28246711066_52e38bc591_z

MHRA sets out Brexit implementation period plan

August 7, 2018 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, MHRA, UK, brexit, implentation period

The UK Medicines and Healthcare products Regulatory Agency (MHRA) have released an update which sets out what pharmaceutical and healthcare …
News
omeros_logo_home_resized

Sanofi’s Dr Eckhard Leifke joins Seattle-based biotech Omeros

August 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Dr Eckhard Leifke, Omeros, Sanofi, Seattle, Takeda

The Seattle-based biotech Omeros have announced that Sanofi’s Dr Eckhard Leifke will join the commercial-stage biopharmaceutical company as Chief Medical …
Appointment
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026